FRS2 and breast cancer: Fibroblast growth factor receptor substrate 2 (FRS2) acts upstream of the FGF signaling pathway, is an adaptor protein expressed in a small subset of epithelial cells and triggers a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis [46].